Efectos de la tensión superficial del caldo de aplicación sobre las magnitudes de variables proporcionadas por los programas CIR 1.5 Y SYLCOMP AG.

Se analizaron los efectos de la disminución de la tensión superficial del caldo de aplicación sobre las variables que caracterizan la población de gotas (cobertura, DVM, DNM relación DVM/DNM y eficiencia de aplicación) sobre papel hidrosensible CF 1, que proporcionan los programas CIR 1.5 y Sylcomp AG. Se utilizaron dos tensioactivos comerciales (Novadox y Silwet), a las concentraciones recomendadas habitualmente. Se realizaron 3 experimentos distintos en los que se mantuvo constante la punta de pulverización (TT 110 02), la presión de trabajo (1,5 bares), la distancia entre picos (0,7 m) y la altura de aplicación (0,7 m), pero se varió la velocidad de avance, lo que produjo distintas tasas de aplicación (62,14 l/ha; 89,19 l/ha y 102 l /ha). Los tensioactivos tuvieron un comportamiento diferencial en cuanto a la disminución de la tensión superficial. Fueron necesarias mayores concentraciones de Novadox que de Silwet para lograr los mismos niveles de esa característica del caldo. El Novadox produjo un descenso proporcional a la concentración y el Silwet aún a la mínima concentración de uso, redujo la tensión superficial a un valor tal que no se modificó por el agregado de producto. Los programas en cuestión proporcionaron valores diferentes de las magnitudes que caracterizan a las poblaciones de gotas. Siempre el CIR 1.5 sobre estimó el DVM (hasta 3 veces) con respecto al Sylcomp AG, mientras que este efectuó estimaciones de mayor valor del DNM (hasta 0,5 veces). La cobertura determinada fue mayor en el CIR 1.5 que en el Sylcomp AG y no se obtuvieron diferencias en las coberturas con las modificaciones de la tensión superficial (de 72 din/cm a 20 din/cm), independientemente de las tasas de aplicación y de los tensioactivos usados. La eficiencia de aplicación sólo fue modificada cuando se utilizó el Silwet y a la mayor tasa de aplicación, y ello se correspondió con las modificaciones de las variables de dimensiones de las gotas (DVM y DNM). No se obtuvieron evidencias que los programas puedan detectar superposiciones de gotas en la mancha sobre el papel y al desconocerse los coeficientes de expansión que utilizan los mismos (Relación diámetro de la mancha/diámetro esférico). Se concluyó que los programas efectúan distintas estimaciones de las variables en cuestión, por lo que las bases de datos deberán construirse usando siempre el mismo programa

Comparison of energy transfer between Terbium and Ytterbium ions in glass and glass ceramic: Application in photovoltaic

The structural and optical properties of thin layers based on 70%SiO 2 –30%HfO 2 doped with different concentra- tion of rare earth ions (terbium and ytterbium) have been studied with a view to integrating them in a photovoltaic cell as a spectral conversion layer in order to improve its efficiency, by using down-conversion process. These thin films were synthesized by using sol gel technique and deposited on the pure silica substrate by dip-coating method. The DC layer can be placed on the front side of a solar cell and can enhance the current by converting ultraviolet (UV) photons into a large number of visible photons. In present study two series of samples are compared, the first series corresponds to samples treated at 900 °C (glass- S) while the second series concerns samples treated at 1000 °C (glass-ceramic- SC). These series are based on 70SiO 2 –30HfO 2 activated by different molar concentrations of rare earths [Tb + Yb]/[Si + Hf] = 7%, 9%, 12%, 15%, 17%, 19% and 21%. Photoluminescence results of reference samples (without Yb 3 + ) showed an emission from 5 D 4 to 7 F J ( J = 3, 4, 5, 6) level characteristic transitions of Tb 3 + , with a maximum peak in the green centered at 543.5 nm cor- responding to the 5 D 4 →7 F 5 transition. For the co-doped samples a clear NIR PL emission around 980 nm was detected, due to the 2 F 5/2 →2 F 7/2 transition of Yb 3 + ions. From luminescence decay curves of Tb 3 + maximum emission peak ( 7 F 5 →5 D 4 transition at 543.5 nm) we have identified the energy transfer efficiency. The quantum efficiency increases by increasing the total [Tb + Yb] concentration. The most significant yield was achieved with [Tb + Yb] = 19%, the maximum quantum transfer efficiency obtained was 190% for glass-ceramic samples and 161% for glassy one

Silver doping of silica-hafnia waveguides containing Tb3+/Yb3+ rare earths for downconversion in PV solar cells

The aim of this paper is to study the possibility to obtain an efficient downconverting waveguide which combines the quantum cutting properties of Tb3+/Yb3+ codoped materials with the optical sensitizing effects provided by silver doping. The preparation of 70SiO(2)-30HfO(2) glass and glass-ceramic waveguides by sol-gel route, followed by Ag doping by immersion in molten salt bath is reported. The films were subsequently annealed in air to induce the migration and/or aggregation of the metal ions. Results of compositional and optical characterization are given, providing evidence for the successful introduction of Ag in the films, while the photoluminescence emission is strongly dependent on the annealing conditions. These films could find potential applications as downshifting layers to increase the efficiency of PV solar cells. (C) 2016 Elsevier B.V. All rights reserved

Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern

Background: Recent in-vitro data have shown that the activity of monoclonal antibodies (mAbs) targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) varies according to the variant of concern (VOC). No studies have compared the clinical efficacy of different mAbs against Omicron VOC. Methods: The MANTICO trial is a non-inferiority randomised controlled trial comparing the clinical efficacy of early treatments with bamlanivimab/etesevimab, casirivimab/imdevimab, and sotrovimab in outpatients aged 50 or older with mild-to-moderate SARS-CoV-2 infection. As the patient enrolment was interrupted for possible futility after the onset of the Omicron wave, the analysis was performed according to the SARS-CoV-2 VOC. The primary outcome was coronavirus disease 2019 (COVID-19) progression (hospitalisation, need of supplemental oxygen therapy, or death through day 14). Secondary outcomes included the time to symptom resolution, assessed using the product-limit method. Kaplan-Meier estimator and Cox proportional hazard model were used to assess the association with predictors. Log rank test was used to compare survival functions. Results: Overall, 319 patients were included. Among 141 patients infected with Delta, no COVID-19 progression was recorded, and the time to symptom resolution did not differ significantly between treatment groups (Log-rank Chi-square 0.22, p 0.90). Among 170 patients infected with Omicron (80.6% BA.1 and 19.4% BA.1.1), two COVID-19 progressions were recorded, both in the bamlanivimab/etesevimab group, and the median time to symptom resolution was 5 days shorter in the sotrovimab group compared with the bamlanivimab/etesevimab and casirivimab/imdevimab groups (HR 0.53 and HR 0.45, 95% CI 0.36-0.77 and 95% CI 0.30-0.67, p<0.01). Conclusions: Our data suggest that, among adult outpatients with mild-to-moderate SARS-CoV-2 infection due to Omicron BA.1 and BA.1.1, early treatment with sotrovimab reduces the time to recovery compared with casirivimab/imdevimab and bamlanivimab/etesevimab. In the same population, early treatment with casirivimab/imdevimab may maintain a role in preventing COVID-19 progression. The generalisability of trial results is substantially limited by the early discontinuation of the trial and firm conclusions cannot be drawn. Funding: This trial was funded by the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA). The VOC identification was funded by the ORCHESTRA (Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic) project, which has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement number 101016167. Clinical trial number: NCT05205759

Ultrasound-assessed perirenal fat is related to increased ophthalmic artery resistance index in HIV-1 patients

<p>Abstract</p> <p>Background</p> <p>The introduction of highly active antiretroviral therapy (HAART) has dramatically changed the prognosis of human immunodeficiency virus (HIV) infection, with a significant decline in morbidity and mortality.</p> <p>Changes in body fat distribution are a common finding in individuals with HIV infection being treated with antiretrovirals, and this condition (collectively termed lipodystrophy syndrome) is associated with depletion of subcutaneous fat, increased triglycerides and insulin resistance. Obesity, particularly visceral obesity, is associated with increased risk of cardiovascular disease. Therefore, estimating visceral fat distribution is important in identifying subjects at high risk for cardiovascular disease.</p> <p>The aim of our study was to evaluate whether perirenal fat thickness (PRFT), a parameter of central obesity, is related to ophthalmic artery resistance index (OARI), an index of occlusive carotid artery disease in HIV-1 infected patients.</p> <p>Methods</p> <p>We enrolled 88 consecutive HIV-1-infected patients receiving highly active antiretroviral therapy for more than 12 months, in a prospective cohort study. Echographically measured PRFT and OARI, as well as serum metabolic parameters, were evaluated. PRFT and OARI were measured by 3.75 MHz convex and 7.5 MHz linear probe, respectively.</p> <p>Results</p> <p>The means of PRFT and OARI in HIV-1-infected patients with visceral obesity was considerably higher than in patients without it (p < 0.0001 and p < 0.001, respectively). Using the average OARI as the dependent variable, total serum cholesterol level, HDL, triglycerides, glycemia, sex, blood pressure, age and PRFT were independent factors associated with OARI. A PRFT of 6.1 mm was the most discriminatory value for predicting an OARI > 0.74 (sensitivity 78.9%, specificity 82.8%).</p> <p>Conclusions</p> <p>Our data indicate that ultrasound assessment of PRFT may have potential as a marker of increased endothelial damage with specific involvement of the ocular vascular region in HIV-1-infected patients.</p

Tb3+/Yb3+ codoped silica-hafnia glass and glass-ceramic waveguides to improve the efficiency of photovoltaic solar cells

In this paper we present the investigation of the energy transfer efficiency between Tb3+ and Yb3+ ions in silica-hafnia waveguides. Cooperative energy transfer between these two ions allows to cut one 488 nm photon in two 980 nm photons and could have important applications in improving the performance of photovoltaic solar cells. Previous works revealed that for a given concentration of donors (Tb3+, increasing the number of acceptors (Yb3+) located near to the Tb3+ ion can increase the Tb-Yb transfer probability. However, when increasing the density of active ions, some detrimental effects due to cross-relaxation mechanisms become relevant. On the basis of this observation the sample doping was chosen keeping constant the molar ratio [Yb]/[Tb] = 4 and the total rare earths contents were [Tb + Yb]/[Si + Hf] = 5%, 7%, 9%. The choice of the matrix is another crucial point to obtain an efficient down conversion processes with rare earth ions. To this respect a 70SiO(2)-30HfO(2) waveguide composition was chosen. The comparison between the glass and the glass-ceramic structures demonstrated that the latter is more efficient since it combines the good optical properties of glasses with the optimal spectroscopic properties of crystals activated by luminescent species. A maximum transfer efficiency of 55% was found for the highest rare earth doping concentration

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London